Pol S - Search Results

1

Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.

Bani-Sadr F, Lapidus N, Melchior JC, Ravaux I, Bensalem M, Rosa I, Cacoub P, Pol S, Perronne C, Carrat F. Bani-Sadr F, et al. Among authors: pol s. J Viral Hepat. 2008 Apr;15(4):255-60. doi: 10.1111/j.1365-2893.2007.00939.x. J Viral Hepat. 2008. PMID: 18307589 Clinical Trial.

2

Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.

Pol S, Wesenfelder L, Dubois F, Roingeard P, Carnot F, Driss F, Brechot C, Goudeau A, Berthelot P. Pol S, et al. J Viral Hepat. 1994;1(2):131-7. doi: 10.1111/j.1365-2893.1994.tb00112.x. J Viral Hepat. 1994. PMID: 8790568

3

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Le Guen B, et al. Among authors: pol s. Hepatology. 1997 May;25(5):1250-4. doi: 10.1002/hep.510250531. Hepatology. 1997. PMID: 9141446

4

Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus.

Thiers V, Pol S, Persico T, Carnot F, Zylberberg H, Berthelot P, Bréchot C, Nalpas B. Thiers V, et al. Among authors: pol s. J Viral Hepat. 1998 Mar;5(2):123-30. doi: 10.1046/j.1365-2893.1998.00092.x. J Viral Hepat. 1998. PMID: 9572037

5

Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C.

Pol S, Nalpas B, Bourlière M, Couzigou P, Tran A, Abergel A, Zarski JP, Berthelot P, Bréchot C. Pol S, et al. Hepatology. 2000 Jun;31(6):1338-44. doi: 10.1053/jhep.2000.8089. Hepatology. 2000. PMID: 10827161 Clinical Trial.

6

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.

Zylberberg H, Benhamou Y, Lagneaux JL, Landau A, Chaix ML, Fontaine H, Bochet M, Poynard T, Katlama C, Pialoux G, Bréchot C, Pol S. Zylberberg H, et al. Among authors: pol s. Gut. 2000 Nov;47(5):694-7. doi: 10.1136/gut.47.5.694. Gut. 2000. PMID: 11034587 Free PMC article.

7

[Management of C virus infection in patients coinfected with HIV treated with antiretroviral agents].

Pol S. Pol S. Presse Med. 2001 Apr 14;30(14):677-82. Presse Med. 2001. PMID: 11360730 Review. French.

8

Characteristics and treatment of hepatitis C virus infection in HIV-coinfected subjects.

Zylberberg H, Pol S. Zylberberg H, et al. Among authors: pol s. AIDS Patient Care STDS. 1998 Jan;12(1):11-9. doi: 10.1089/apc.1998.12.11. AIDS Patient Care STDS. 1998. PMID: 11361880 Review.

9

Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy.

Pol S, Vallet-Pichard A, Fontaine H. Pol S, et al. J Viral Hepat. 2002 Jan;9(1):1-8. doi: 10.1046/j.1365-2893.2002.00326.x. J Viral Hepat. 2002. PMID: 11851897 Review.

10

Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease.

Hüe S, Cacoub P, Renou C, Halfon P, Thibault V, Charlotte F, Picon M, Rifflet H, Piette JC, Pol S, Caillat-Zucman S. Hüe S, et al. Among authors: pol s. J Infect Dis. 2002 Jul 1;186(1):106-9. doi: 10.1086/341086. Epub 2002 May 31. J Infect Dis. 2002. PMID: 12089669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

941 results

Search Page

Filters